Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001219036-21-000002

Chief Scientific Officer sold 80,000 shares at $29.71 ($2,377,048)

  • Chief Scientific Officer acquired 80,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
LANCHBURY JERRY S Chief Scientific Officer 2021-02-16 Option exercise +74,445 $18.00 $1,340,010 321,020 D: show line 1 in the form
LANCHBURY JERRY S Chief Scientific Officer 2021-02-16 Sale −74,445 $29.71 $2,211,992 246,575 D: show line 2 in the form
LANCHBURY JERRY S Chief Scientific Officer 2021-02-16 Option exercise +5,555 $18.00 $99,990 252,130 D: show line 3 in the form
LANCHBURY JERRY S Chief Scientific Officer 2021-02-16 Sale −5,555 $29.71 $165,056 246,575 D: show line 4 in the form
Open-market sales · 80,000 sh · avg $29.71 · $2,377,048

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
LANCHBURY JERRY S Chief Scientific Officer 2021-02-16 Option exercise · Incentive Stock Option (right to buy) −5,555 0 D: show line 5 in the form
LANCHBURY JERRY S Chief Scientific Officer 2021-02-16 Option exercise · Non-Qualified Stock Option (right to buy) −74,445 0 D: show line 6 in the form
Loading xslF345X03/edgardoc.xml…